Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1987-11-23
1989-05-16
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 551, 536 553, 536 53, 536123, A61K 3170
Patent
active
048310212
ABSTRACT:
A novel mono-sialo ganglioside derivative substantially identical chemically and physically with a product prepared by
REFERENCES:
patent: 4125492 (1978-11-01), Cuatrecasas et al.
patent: 4415733 (1983-11-01), Tayot
patent: 4464360 (1984-08-01), Leffler et al.
patent: 4521593 (1985-06-01), Martin
Lundblad et al., "Eur. Jour. Biochem.," 104, pp. 323-330, 1980.
Leffler et al., "Fems. Microbiology Letters", 8, pp. 127-134, 1980.
Biochemistry, vol. 17, No. 13, 27th Jun. 1978, pp. 2619-2628, American Chemical Society; L. O. Sillerud et al., "Assignment of the 13c nuclear magnetic resonance spectrum of aqueous ganglioside GMI micelles".
Cavallo Giovanni
Tubaro Ezio
Brown Donald
Burroughs Wellcome Co.
Griffin Ronald W.
LandOfFree
Ganglioside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ganglioside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ganglioside derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2322741